DXR

MKT CAP:$53M

Daxor Corporation

Market Cap

$53M

Healthcare·Medical - Instruments & Supplies·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$9.85-$4.51 (-31.41%)

Apr 21, 2026

Company Details

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, ob...

CEO

Michael Richard Feldschuh

IPO Date

Jul 25, 1983

Website

www.daxor.com

Key Metrics TTM

Revenue

$917.3K

+132.2% YoY

Net Income

$10M

EPS (Diluted)

$1.92

Free Cash Flow

-$1M

Revenue / Share

$0.18

Gross Margin

66.1%

Operating Margin

1219.0%

Net Margin

1058.2%

FCF Margin

-133.7%

P/S

58.3x

P/E

5.5x

Earnings Reports

FY 2025

Dec 30, 2025

$503.4K-76.4%EPS $1.84

Q4 2025

Dec 30, 2025

$131.8K-81.0%EPS $1.89

Q2 2025

Jun 30, 2025

$18.3K-74.4%EPS -$0.07

FY 2024

Dec 31, 2024

$2M-93.8%EPS $0.11

Q4 2024

Dec 31, 2024

$695.3K+743.3%EPS $0.44

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q2 18	$229.5K	-$84.1K	$115.7K
Q4 18	$200.4K	-$179.2K	$57.5K
Q2 19	$192.9K	$192.9K	$32.4K
Q4 19	$187.2K	$187.2K	-$10.9K
Q2 20	$118.9K	$118.9K	-$103.7K
Q4 20	$145.5K	$145.5K	-$234.2K
Q2 21	$125.7K	$125.7K	-$296.6K
Q4 21	$152.4K	$152.4K	-$449.0K
Q2 22	$135.2K	$135.2K	-$235.5K
Q4 22	$96.4K	$96.4K	-$624.2K
Q2 23	$81.0K	$81.0K	-$366.5K
Q4 23	$82.4K	$82.4K	$3M
Q2 24	$71.8K	$71.8K	-$297.6K
Q4 24	$695.3K	$620.7K	$2M
Q2 25	$18.3K	$18.3K	-$269.5K
Q4 25	$131.8K	-$104.6K	$10M

Valuation

Quarter	P/S	P/E
Q2 18	51.3x	—
Q4 18	54.5x	—
Q2 19	59.5x	—
Q4 19	66.0x	—
Q2 20	76.4x	—
Q4 20	82.9x	—
Q2 21	92.6x	—
Q4 21	98.5x	17.6x
Q2 22	95.7x	11.2x
Q4 22	104.9x	5.4x
Q2 23	115.0x	6.3x
Q4 23	135.3x	9.8x
Q2 24	161.2x	9.5x
Q4 24	57.5x	65.4x
Q2 25	61.6x	15.3x
Q4 25	58.3x	5.5x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q2 18	$4.1K	$4.1K
Q4 18	-$1M	-$1M
Q2 19	$57.5K	$57.5K
Q4 19	-$2M	-$2M
Q2 20	-$1M	-$1M
Q4 20	-$2M	-$2M
Q2 21	-$1M	-$1M
Q4 21	-$1M	-$1M
Q2 22	-$2M	-$2M
Q4 22	-$2M	-$2M
Q2 23	-$3M	-$3M
Q4 23	-$4M	-$4M
Q2 24	-$894.0K	-$894.0K
Q4 24	-$502.0K	-$502.1K
Q2 25	$467.0K	$467.0K
Q4 25	-$297.5K	-$297.5K

Capital Expenditures

Quarter	CapEx
Q2 18	$0
Q4 18	$0
Q2 19	$0
Q4 19	$0
Q2 20	$0
Q4 20	$0
Q2 21	$0
Q4 21	$0
Q2 22	$0
Q4 22	$0
Q2 23	$0
Q4 23	$0
Q2 24	$3
Q4 24	$3
Q2 25	$4
Q4 25	$4

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q2 18	-16.1%	-39.3%
Q4 18	-23.0%	+21.8%
Q2 19	-30.1%	+179.2%
Q4 19	-32.0%	+195.4%
Q2 20	-48.2%	+95.7%
Q4 20	-27.4%	+165.6%
Q2 21	-34.9%	+163.0%
Q4 21	-18.6%	+203.5%
Q2 22	+13.7%	+66.5%
Q4 22	-33.7%	+89.8%
Q2 23	-35.6%	+6.0%
Q4 23	-45.9%	-595.9%
Q2 24	-46.9%	-0.4%
Q4 24	+621.3%	-309.5%
Q2 25	-77.3%	-35.7%
Q4 25	+59.9%	-215.5%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q2 18	$34.1K	14.9%
Q4 18	$49.7K	24.8%
Q2 19	$52.9K	27.4%
Q4 19	$46.8K	25.0%
Q2 20	$81.8K	68.7%
Q4 20	$107.0K	73.6%
Q2 21	$183.4K	145.9%
Q4 21	$181.3K	118.9%
Q2 22	$137.7K	101.8%
Q4 22	$255.6K	265.1%
Q2 23	$162.1K	200.2%
Q4 23	$153.7K	186.4%
Q2 24	$275.7K	384.2%
Q4 24	$0	0.0%
Q2 25	$205.2K	1118.5%
Q4 25	$0	0.0%

OpEx Breakdown

Quarter	G&A	S&M
Q2 18	$113.8K	—
Q4 18	$142.9K	—
Q2 19	$160.6K	—
Q4 19	$223.6K	—
Q2 20	$222.7K	—
Q4 20	$370.8K	—
Q2 21	$419.7K	—
Q4 21	$571.6K	—
Q2 22	$364.0K	—
Q4 22	$721.4K	—
Q2 23	$436.0K	—
Q4 23	$128.7K	$374.3K
Q2 24	$93.6K	$275.7K
Q4 24	$200.6K	$969.9K
Q2 25	$82.6K	$205.2K

War Chest

Quarter	Cash	Short-term Investments	Total
Q2 18	$0	$0	$0
Q4 18	$0	$0	$0
Q2 19	$0	$0	$0
Q4 19	$0	$0	$0
Q2 20	$3M	$0	$3M
Q4 20	$617.8K	$0	$617.8K
Q2 21	$628.7K	$0	$628.7K
Q4 21	$710.7K	$0	$710.7K
Q2 22	$0	$0	$0
Q4 22	$0	$0	$0
Q2 23	$0	$0	$0
Q4 23	$0	$0	$0
Q2 24	$0	$0	$0
Q4 24	$0	$0	$0
Q2 25	$0	$0	$0
Q4 25	$0	$0	$0

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q2 18	4M	-0.2%	-2.5%
Q4 18	4M	+0.5%	-1.4%
Q2 19	4M	+11.7%	+10.4%
Q4 19	4M	0.0%	+12.0%
Q2 20	4M	0.0%	+12.3%
Q4 20	8M	+92.7%	+115.3%
Q2 21	8M	0.0%	+92.7%
Q4 21	8M	+0.1%	+92.9%
Q2 22	8M	+0.1%	+93.1%
Q4 22	9M	+6.2%	+6.4%
Q2 23	7M	-23.0%	-18.1%
Q4 23	5M	-29.9%	-42.7%
Q2 24	5M	+4.3%	-40.2%
Q4 24	5M	+2.2%	-42.5%
Q2 25	5M	+1.0%	-24.6%
Q4 25	5M	+1.5%	+9.2%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q2 18	$6.2K	37
Q4 18	$5.4K	37
Q2 19	$5.2K	37
Q4 19	$5.1K	37
Q2 20	$3.2K	37
Q4 20	$3.9K	37
Q2 21	$3.4K	37
Q4 21	$4.1K	37
Q2 22	$3.7K	37
Q4 22	$2.6K	37
Q2 23	$2.2K	37
Q4 23	$2.2K	37
Q2 24	$1.9K	37
Q4 24	$18.8K	37
Q2 25	$496	37
Q4 25	$3.6K	37

Revenue / Employee